| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $25K | -68.7% | -61.5% |
| SG&A Expense | $208K | +10.9% | -36.2% |
| Operating Income | -$233K | +13.1% | +40.5% |
| Interest Expense | $31K | +22.2% | +303.0% |
| Net Income | -$286K | +9.4% | +6.0% |
| EPS (Diluted) | $0.00 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $43K | +104.3% | -32.3% |
| Total Assets | $94K | +15.7% | -37.4% |
| Current Liabilities | $2.0M | +5.3% | -10.2% |
| Long-term Debt | $928K | +9.4% | — |
| Total Liabilities | $3.4M | +5.6% | +51.8% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$634K | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $483K | — | — |
| — |
| -$3.3M |
| -5.3% |
| -58.2% |